2017
DOI: 10.1016/j.morpho.2017.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Microstructural alterations owing to handling of bovine pericardium to manufacture bioprosthetic heart valves: A potential risk for cusp dehiscence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 40 publications
1
8
0
2
Order By: Relevance
“…For patients with hepatic failure, when performing thoracotomy, the bilateral pleura should not be opened. If pleural damage and breakage is observed, an autologous or allogeneic pericardial patch should be used to close the breakage (29), and this is essential to prevent postoperative wound dehiscence, exudation and infection (30,31). A sternal incision, intercostal incision or a robot can be used to perform coronary artery bypass graft.…”
Section: Discussionmentioning
confidence: 99%
“…For patients with hepatic failure, when performing thoracotomy, the bilateral pleura should not be opened. If pleural damage and breakage is observed, an autologous or allogeneic pericardial patch should be used to close the breakage (29), and this is essential to prevent postoperative wound dehiscence, exudation and infection (30,31). A sternal incision, intercostal incision or a robot can be used to perform coronary artery bypass graft.…”
Section: Discussionmentioning
confidence: 99%
“…Adverse events related to bovine pericardium heart valves have been well documented. The structure of the collagen bundles in the leaflets acts as a key factor in determining the in vivo fate of the valves . The preservation of the wavy structure and individualized collagen filaments is known to play an important part in determining the mechanical properties of the pericardium.…”
Section: Introductionmentioning
confidence: 99%
“…Bioprostheses afford patients the opportunity to avoid rigorous anticoagulation in exchange for limited long-term durability secondary to wellrecognized modes of failure. [1][2][3] Valvular heart disease remains a global management challenge of access to optimal therapy, especially in children and in developing countries where rheumatic disease remains prevalent. 4 The ideal valve prosthesis provides for nonthrombogenic long-term durability and the potential to adapt to somatic growth.…”
mentioning
confidence: 99%